Nasdaq agrx.

Find the latest SEC Filings data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.Agile Therapeutics, Inc. Common Stock (AGRX) Advanced Charting - Nasdaq offers advanced charting & market activity data for US and global markets. Nasdaq +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Agile Therapeutics, Inc. (AGRX) NasdaqCM - NasdaqCM Real...Feb 16, 2021 · Agile Therapeutics (NASDAQ:AGRX) is a commercial-stage pharmaceutical company selling its recently approved Twirla patch.I have followed the AGRX story for quite some time, first publishing "400% ... The Company’s common stock will open for trading on the Nasdaq Market on Wednesday, April 27, 2022 on a split-adjusted basis under the current trading symbol "AGRX."

PRINCETON, N.J., July 18, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the appointment of Dennis P. Reilly as Chief Financial ...PRINCETON, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare company, today announced that on December 11, 2018, it met with the U.S. Food ...

Find the latest Revenue & EPS data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.

PRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report second quarter 2023 financial results ...The Company’s common stock will open for trading on the Nasdaq Market on Wednesday, April 27, 2022 on a split-adjusted basis under the current trading symbol "AGRX."Agile Therapeutics Inc. (NASDAQ: AGRX) Avadel Pharmaceuticals Plc (NASDAQ: AVDL) Venator Materials Plc Agile Therapeutics Inc. (NASDAQ: AGRX) Agile Therapeutics is one of the bigger gainers so far today with over 19% in gains during morning trading. This comes after a five day and one month drop of more than 19% and over 45%.Feb 27, 2023 · PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile” or the “Company”), a women's healthcare company, today announced that it has received ...

PRINCETON, N.J., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced the launch of I’m So Done, an ...

15 Jun 2023 ... Agile's Capital Raise Strategies In A Competitive Market: NASDAQ: $AGRX CEO Al Altomari's Approach. 80 views · 2 months ago #WomensHealth #AGRX

Jun 28, 2022 · Agile Therapeutics (NASDAQ: AGRX), a women's healthcare company, reported increasing Twirla prescription data for the first quarter 2022.Twirla cycles dispensed increased 29% to 16,602; Total ... PRINCETON, N.J., March 15, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women's healthcare company, today announced that an abstract presenting data from two Phase 1 in ...Agile Therapeutics Inc (NASDAQ:AGRX) is the most popular stock in this table. On the other hand Clearfield, Inc. (NASDAQ:CLFD) is the least popular one with only 3 bullish hedge fund positions.Agile Therapeutics Inc. (NASDAQ: AGRX) Avadel Pharmaceuticals Plc (NASDAQ: AVDL) Venator Materials Plc Agile Therapeutics Inc. (NASDAQ: AGRX) Agile Therapeutics is one of the bigger gainers so far today with over 19% in gains during morning trading. This comes after a five day and one month drop of more than 19% and over 45%.Nasdaq +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Agile Therapeutics, Inc. (AGRX) NasdaqCM - NasdaqCM Real...Mar 27, 2023 · March 26, 2023 at 11:25 PM · 10 min read. Agile Therapeutics, Inc. (NASDAQ: AGRX) Q4 2022 Earnings Call Transcript March 24, 2023. Operator: Good afternoon and welcome to the Agile Therapeutics ... The Company’s common stock will open for trading on the Nasdaq Market on Wednesday, April 27, 2022 on a split-adjusted basis under the current trading symbol "AGRX."

Shares of NASDAQ AGRX opened at $2.16 on Friday. The firm has a market capitalization of $5.42 million, a PE ratio of -0.16 and a beta of 1.81. The firm’s 50-day moving average is $1.99 and its ...Find the latest Earnings Report Date for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58.PRINCETON, N.J., April 28, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced preliminary expectations for first quarter 2023 Twirla ...The purchase of more than 5.73 million Agile Therapeutics Inc (NASDAQ:AGRX) shares by a beneficial owner at about $0.85 apiece totaled over $4.87 million. The owner's stake in this contraceptives ...November 20, 2023 at 1:14 PM PST. Listen. 1:51. The Nasdaq 100 Stock Index closed at the highest in nearly two years, with tech stocks gaining on high expectations for artificial …

The Nasdaq Composite was lagging behind the other major stock indexes on Thursday as bond yields turned higher. The Nasdaq was down 0.3%, while the S&P 500 …

Apr 26, 2023 · PRINCETON, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it has received a notification letter from the ... If you would like to register as a market maker in AGRX, contact Nasdaq Trading Operations at +1 212 231 5100. Email Alert Subscriptions: Nasdaq offers customers the ability to self select news delivery across various Nasdaq markets.On Mar. 31, he reported buying 10,000 shares at an average price of $20.17. This case of insider buying is a personal investment of over $200,000. Wall Street also thinks that the shares are ...PRINCETON, N.J., July 12, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new ...PRINCETON, N.J., April 22, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced that the company has nominated Sharon ...PRINCETON, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today applauded House Congressional Committee leaders in urging the ...PRINCETON, N.J., May 22, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the pricing of its ...

Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, and more asset classes. Add/Edit Symbols Edit …

Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4) PRINCETON, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the granting of a previously disclosed inducement award to the...

PRINCETON, N.J., June 15, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Twirla will become available through FPA Women’s ...Agile Therapeutics Inc (NASDAQ:AGRX) shares are down by over 99% in the last year and down almost 72% in the last three months. As of this writing, Agile Therapeutics shares are trading at above $0.38 (52-week range of $0.37 to $50.40), giving it a market capitalization of more than $15 million.The purchase of more than 5.73 million Agile Therapeutics Inc (NASDAQ:AGRX) shares by a beneficial owner at about $0.85 apiece totaled over $4.87 million. The owner's stake in this contraceptives ...We closed out the fourth quarter 2021 with a net loss of $23.4 million or $0.20 per share compared to the net loss of $17.6 million or $0.20 per share for the comparable period in 2020. The full ... As of March 2015, Theranos is a private company and does not have a public stock symbol. The medical technology company has a partnership with the public company, Walgreens, which has a stock symbol of WAG on Nasdaq.PRINCETON, N.J., July 23, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of ...Jun 27, 2017 · AGRX tried to move up and failed, broke the support level yesterday, and is now trading below it. Our idea is to take AGRX if it breaks the $ 1.97 price for further dec Hi traders, The consumer sector has been in a sharp decline in recent days and we have a trading idea in AGRX for further declines. AGRX tried to move up and failed, broke the ... PRINCETON, N.J., April 28, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced preliminary expectations for first quarter 2023 Twirla ...PRINCETON, N.J., July 18, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the appointment of Dennis P. Reilly as Chief Financial ...

PRINCETON, N.J., April 28, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced preliminary expectations for first quarter 2023 Twirla ...AGRX Sales Forecast. Next quarter’s sales forecast for AGRX is $9.20M with a range of $9.20M to $9.20M. The previous quarter’s sales results were $6.66M. AGRX beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 46.22% of the time in the same period. PRINCETON, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it intends to offer and sell shares of its common ...Instagram:https://instagram. auroracannabis stocksell my broken iphoneonline motorcycle insurance quote state farmtastytrade day trade counter According to the issued ratings of 2 analysts in the last year, the consensus rating for Agile Therapeutics stock is Buy based on the current 2 buy ratings for AGRX. The average twelve-month price prediction for Agile Therapeutics is $8.50 with a high price target of $12.00 and a low price target of $5.00. Learn more on AGRX's analyst rating ... news on world war 3best municipal bond funds 2023 Webull offers Agile Therapeutics Inc stock information, including NASDAQ: AGRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate …Agile Therapeutics, Inc. Common Stock (AGRX) Advanced Charting - Nasdaq offers advanced charting & market activity data for US and global markets. is td ameritrade good for day trading 15 Jun 2023 ... Agile's Capital Raise Strategies In A Competitive Market: NASDAQ: $AGRX CEO Al Altomari's Approach. 80 views · 2 months ago #WomensHealth #AGRXPRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today reported financial results for the three months ended June 30 ...